Bedel Financial Consulting’s Johnson & Johnson JNJ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $3.32M | Sell |
13,084
-115
| -0.9% | -$26.8K | 0.31% | 42 |
|
|
2026
Q1 | $3.23M | Sell |
13,199
-99
| -0.7% | -$23.1K | 0.36% | 40 |
|
|
2025
Q4 | $2.75M | Sell |
13,298
-914
| -6% | -$181K | 0.3% | 46 |
|
|
2025
Q3 | $2.64M | Buy |
14,212
+334
| +2% | +$57.2K | 0.34% | 42 |
|
|
2025
Q2 | $2.12M | Sell |
13,878
-873
| -6% | -$134K | 0.29% | 46 |
|
|
2025
Q1 | $2.28M | Sell |
14,751
-127
| -0.9% | -$19.9K | 0.33% | 41 |
|
|
2024
Q4 | $2.3M | Buy |
14,878
+973
| +7% | +$151K | 0.32% | 43 |
|
|
2024
Q3 | $2.25M | Sell |
13,905
-248
| -2% | -$39.5K | 0.32% | 39 |
|
|
2024
Q2 | $2.07M | Sell |
14,153
-323
| -2% | -$48K | 0.3% | 37 |
|
|
2024
Q1 | $2.29M | Buy |
14,476
+14
| +0.1% | +$2.23K | 0.36% | 31 |
|
|
2023
Q4 | $2.27M | Sell |
14,462
-484
| -3% | -$74.2K | 0.42% | 29 |
|
|
2023
Q3 | $2.33M | Buy |
14,946
+73
| +0.5% | +$12K | 0.47% | 26 |
|
|
2023
Q2 | $2.46M | Buy |
14,873
+52
| +0.4% | +$8.39K | 0.51% | 24 |
|
|
2023
Q1 | $2.3M | Buy |
14,821
+219
| +1% | +$35.4K | 0.56% | 25 |
|
|
2022
Q4 | $2.58M | Buy |
14,602
+223
| +2% | +$38.5K | 0.64% | 22 |
|
|
2022
Q3 | $2.49M | Buy |
14,379
+27
| +0.2% | +$4.57K | 0.66% | 19 |
|
|
2022
Q2 | $2.55M | Buy |
14,352
+708
| +5% | +$126K | 0.75% | 15 |
|
|
2022
Q1 | $2.42M | Buy |
13,644
+189
| +1% | +$32.2K | 0.76% | 13 |
|
|
2021
Q4 | $2.3M | Sell |
13,455
-1,404
| -9% | -$230K | 0.72% | 13 |
|
|
2021
Q3 | $2.4M | Buy |
14,859
+38
| +0.3% | +$6.48K | 0.82% | 12 |
|
|
2021
Q2 | $2.44M | Buy |
14,821
+509
| +4% | +$84.3K | 0.85% | 11 |
|
|
2021
Q1 | $2.35M | Buy |
14,312
+3,584
| +33% | +$580K | 0.91% | 11 |
|
|
2020
Q4 | $1.69M | Buy |
10,728
+2
| +0% | +$295 | 0.75% | 13 |
|
|
2020
Q3 | $1.6M | Sell |
10,726
-23
| -0.2% | -$3.4K | 0.8% | 13 |
|
|
2020
Q2 | $1.51M | Sell |
10,749
-820
| -7% | -$119K | 0.82% | 13 |
|
|
2020
Q1 | $1.52M | Sell |
11,569
-752
| -6% | -$107K | 1% | 13 |
|
|
2019
Q4 | $1.8M | Sell |
12,321
-12
| -0.1% | -$1.63K | 1.02% | 12 |
|
|
2019
Q3 | $1.6M | Sell |
12,333
-143
| -1% | -$18.8K | 0.96% | 16 |
|
|
2019
Q2 | $1.74M | Sell |
12,476
-148
| -1% | -$20.5K | 1.06% | 13 |
|
|
2019
Q1 | $1.76M | Buy |
12,624
+2
| +0% | +$268 | 1.13% | 11 |
|
|
2018
Q4 | $1.63M | Sell |
12,622
-563
| -4% | -$78.5K | 1.17% | 8 |
|
|
2018
Q3 | $1.8M | Buy |
13,185
+62
| +0.5% | +$8.24K | 1.2% | 10 |
|
|
2018
Q2 | $1.59M | Buy |
13,123
+1,194
| +10% | +$149K | 1.17% | 11 |
|
|
2018
Q1 | $1.53M | Buy |
11,929
+126
| +1% | +$17K | 1.16% | 10 |
|
|
2017
Q4 | $1.65M | Buy |
+11,803
| New | +$1.64M | 1.48% | 10 |
|
Other funds holding JNJ
AACR
Bedel Financial Consulting's JNJ Position: Q2 2026 in Review
Bedel Financial Consulting reduced its Johnson & Johnson (JNJ) stake by 0.87% in Q2 2026, selling an estimated $26.8K and leaving 13,084 shares worth $3.32M. The position accounts for 0.31% of the portfolio, ranked #42.
Bedel Financial Consulting first reported a position in JNJ in Q4 2017 and has held it in 35 quarters since. 2,377 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.
- Bedel Financial Consulting held 13,084 shares of Johnson & Johnson worth $3.32M as of Q2 2026.
- Bedel Financial Consulting sold 115 Johnson & Johnson shares in Q2 2026, an estimated $26.8K.
- Johnson & Johnson made up 0.31% of Bedel Financial Consulting's portfolio in Q2 2026, its #42 holding.
- Bedel Financial Consulting first reported a position in Johnson & Johnson in Q4 2017 and has held it in 35 quarters since.
- 2,377 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.
Based on Bedel Financial Consulting's 13F filing for Q2 2026, filed 29 Jul 2026.